CBD Administration Associated with Improved Quality of Life in Patients with Parkinson’s Disease

Tags: , , |

By Paul Armentano, NORML Deputy Director Investigators at the University of São Paulo in Brazil assessed the efficacy of CBD versus placebo in 21 subjects with Parkinson’s. Authors reported that the administration of 300 mg doses of CBD per day was associated with “significantly different mean total scores” in subjects’ well-being and quality of life